Skip to main content
. 2022 Jan 11;32(5):589–598. doi: 10.1136/tobaccocontrol-2021-056825

Table 1.

Model summary (in descending order of the number of peer-reviewed articles)

Model name/first author: SimSmoke
Model type (self-reported): discrete Markov model, macrosimulation
Risk factors included (smoking status provided with details): smoking status (never, former, current), years since quitting
Diseases: NA
Outcomes: mortality, smoking prevalence, maternal and child health outcomes (smoking-attributable low birth weight, preterm births and sudden infant death syndrome) cases, uncertainty
Sensitivity analysis: performed sensitivity analysis
Validation: External validation
Number of peer-reviewed articles in this search: 18
Related papers: 24 26–42
Model name/first author: Burden of Disease Epidemiology, Equity and Economics model
Model type (self-reported): a proportional multistate life-table, macrosimulation, Markov model
Risk factors included (smoking status provided with details): smoking status (never, former, current)
Diseases: 16 diseases—CHD, stroke, COPD, lower respiratory tract infection, and multiple cancers: lung, oesophageal, stomach, liver, head and neck, pancreas, cervical, bladder, kidney, endometrial, melanoma, and thyroid (with smoking protecting against the latter three cancers)
Outcomes: equity, health-systems cost-savings, smoking prevalence, QALYs gained, health-adjusted life years, uncertainty
Sensitivity analysis: PSA
Validation: cross-validation, external validation
Number of peer-reviewed articles in this search: 11
Related papers: 20 25 43–51
Model name/first author: IMPACT
Model type (self-reported): cell-based model
Risk factors included (smoking status provided with details): blood pressure, cholesterol, diabetes, fruit and vegetable, smoking status (never smoker, long-term ex-smoker, recent ex-smoker, current smoker), salt intake, saturated fat intake, BMI, physical activities
Diseases: CHD, T2DM
Outcomes: equity, CHD mortality, smoking prevalence, life-years gained, uncertainty
Sensitivity analysis: Monte Carlo simulation
Validation: external validation
Number of peer-reviewed articles in this search: 6
Related papers: 23 107–111
Model name/first author: extended cost-effectiveness analysis (ECEA) tobacco tax model
Model type (self-reported): ECEA
Risk factors included (smoking status provided with details): smoking prevalence, number of cigarettes smoked daily; age at quitting
Diseases: COPD, heart disease, stroke, lung cancer, bladder cancer
Outcomes: disease treatment costs, averted premature death, life-years gained, additional revenues generated, equity, uncertainty
Sensitivity analysis: one-way, Monte Carlo simulation
Validation: validated model
Number of peer-reviewed articles in this search: 5
Related papers: 70–74
Model name/first author: EQUIPTMOD
Model type (self-reported): Markov state-transition cohort model, macrosimulation
Risk factors included (smoking status provided with details): smoking status (former, current)
Diseases: COPD, CHD, stroke, lung cancer
Outcomes: cost, ROI, ICER, QALY
Sensitivity analysis: univariate, others
Validation: no model validation
Number of peer-reviewed articles in this search: 5
Related papers: 112–116
Model name/first author: DYNAMO-HIA model
Model type (self-reported): macrosimulation, Markov-based life-table
Risk factors included (smoking status provided with details): alcohol intake, BMI, smoking status, secondhand smoking
Diseases: COPD, IHD, stroke, cancers, T2DM
Outcomes: mortality, morbidity, morbidity-free years, life expectancy, number of deaths
Sensitivity analysis: performed sensitivity analysis
Validation: no model validation
Number of peer-reviewed articles in this search: 5
Related papers: 94–98
Model name/first author: Benefits of Smoking Cessation on Outcomes model
Model type (self-reported): discrete-time Markov model
Risk factors included (smoking status provided with details): smoker, recent quitter and long-term quitter
Diseases: COPD, CHD, stroke, lung cancer, asthma exacerbation, chronic obstructive lung diseases
Outcomes: total morbidity and mortality, economics impact
Sensitivity analysis: one-way, PSA
Validation:no model validation
Number of peer-reviewed articles in this search: 4
Related papers: 63–66
Model name/first author: Jiménez model
Model type (self-reported): closed cohort Markov model
Risk factors included (smoking status provided with details): smoking status, willingness to quit history
Diseases: COPD, CVD, T2DM
Outcomes: incremental cost-savings, number of quitters
Sensitivity analysis: univariate sensitivity analysis
Validation: internal validation
Number of peer-reviewed articles in this search: 3
Related papers: 89–91
Model name/first author: Johansson model
Model type (self-reported): a Markov model
Risk factors included (smoking status provided with details): smoking status (former, current)
Diseases: COPD, CHD, stroke, cancers
Outcomes: QALY, life years lost, cost, uncertainty
Sensitivity analysis: univariable, multivariable, PSA
Validation: external validation
Number of peer-reviewed articles in this search: 3
Related papers: 17 57 58
Model name/first author: Prevention Impacts Simulation Model
Model type (self-reported): system dynamics model
Risk factors included (smoking status provided with details): blood pressure, cholesterol, secondhand smoking, obesity, psychological distress, fruit and vegetable, smoking status (never smoker, long-term ex-smoker, recent ex-smoker, current smoker), blood glucose categories (normal, pre-diabetic, diabetic), periodontal disease, sleep apnoea, small particulate air pollution and inadequate use of aspirin for primary prevention
Diseases: CVD
Outcomes: mortality and morbidity, healthcare cost, productivity loss, uncertainty
Sensitivity analysis: PSA
Validation: external validation
Number of peer-reviewed articles in this search: 3
Related papers: 75–77
Model name/first author: Baker model
Model type (self-reported): closed cohort Markov model
Risk factors included (smoking status provided with details): eligible smoker, ineligible smoker, initial quitter, successful quitter
Diseases: NA
Outcomes: number of quitters, morbidity, mortality, medical expenditures
Sensitivity analysis: univariate, multivariable analyses
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 99 100
Model name/first author: Barnett model
Model type (self-reported): a Markov model
Risk factors included (smoking status provided with details): smoking status (former, current)
Diseases: NA
Outcomes: mortality, healthcare cost, QALY, uncertainty
Sensitivity analysis: one-way, PSA
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 59 60
Model name/first author: Cantor model
Model type (self-reported): decision-analytical model
Risk factors included (smoking status provided with details): smoking status
Diseases: NA
Outcomes: cost, QALY
Sensitivity analysis: one-way, two-way uncertainty analyses
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 61 62
Model name/first author: Chevreul model
Model type (self-reported): Markov state transition model
Risk factors included (smoking status provided with details): smoking status (smoker, former smoker), diagnosed with either lung cancer, COPD or CVD such as stroke or coronary artery disease and dead (smoker: ≥1 cigarette/day)
Diseases: COPD, CVD, lung cancer
Outcomes: ICER
Sensitivity analysis: deterministic sensitivity analysis, Monte Carlo simulation
Validation: internal validation, external validation
Number of peer-reviewed articles in this search: 2
Related papers: 101 102
Model name/first author: Cost-Effectiveness of Preventing AIDS Complications-US model
Model type (self-reported): microsimulation
Risk factors included (smoking status provided with details): smoking intensity (packs/day)—heavy/moderate/light, CD4+T cell count, viral load, history of opportunistic disease and antiretroviral treatment use
Diseases: lung cancer
Outcomes: life expectancy, mortality
Sensitivity analysis: two-way
Validation: internal validation, external validation and cross-validation
Number of peer-reviewed articles in this search: 2
Related papers: 92 93
Model name/first author: ModelHealth: Tobacco
Model type (self-reported): microsimulation
Risk factors included (smoking status provided with details): smoking status (never, former, current)
Diseases: CVD, stroke, lung cancer, respiratory disease
Outcomes: medical cost, hospitalisation, mortality and morbidity, productivity loss, QALY, smoking prevalence
Sensitivity analysis: one-way
Validation: internal validation, external validation
Number of peer-reviewed articles in this search: 2
Related papers: 103 104
Model name/first author: Parrott model
Model type (self-reported): decision tree
Risk factors included (smoking status provided with details): childhood exposure to maternal smoking, smoking status (current, former)
Diseases: COPD, CHD, stroke, lung cancer, asthma, pregnancy-related (placental abruption, ectopic pregnancy, pre-eclampsia, placenta previa and miscarriage, infant morbidities: low infant birth weight, stillbirth, premature birth)
Outcomes: ICER, QALY, uncertainty
Sensitivity analysis: PSA
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 67 68
Model name/first author: Population Health Impact Model
Risk factors included (smoking status provided with details): never tobacco users, former tobacco users, current cigarette smokers, current cMRTP users, current dual users
Diseases: COPD, IHD, stroke, lung cancer
Outcomes: mortality, cMRTP uptake
Sensitivity analysis: performed sensitivity analysis
Validation: model validated
Number of peer-reviewed articles in this search: 2
Related papers: 18 52
Model name/first author: Tobacco Town
Model type (self-reported): agent-based model
Risk factors included (smoking status provided with details): smoking intensity (cigarettes/day)
Diseases: NA
Outcomes: cost, tobacco purchase behaviour
Sensitivity analysis: performed sensitivity analysis
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 79 80
Model name/first author: UK Health Forum simulation
Model type (self-reported): microsimulation
Risk factors included (smoking status provided with details): smoking status (never, former, current)
Diseases: COPD, CHD, stroke, 14 cancers
Outcomes: cost, morbidity, smoking prevalence, uncertainty
Sensitivity analysis: performed sensitivity analysis
Validation: no model validation
Number of peer-reviewed articles in this search: 2
Related papers: 81 82
Model name/first author: Chronic Disease Model
Model type (self-reported): closed cohort multistate Markov model
Risk factors included (smoking status provided with details): smoking status (never, former, current)
Diseases: acute myocardial infarction, chronic heart failure, COPD, stroke (CVA), T2DM, and cancer of the lung, stomach, oesophagus, larynx, bladder, kidney, pancreas, and oral cavity
Outcomes: cost, QALY, number of quitters
Sensitivity analysis: one-way
Validation: no model validation
Number of peer-reviewed articles in this search: 1
Related papers: 117
Model name/first author: Chronic Heart Disease Policy Model
Model type (self-reported): state-transition (Markov) computer-simulation model
Risk factors included (smoking status provided with details): active smoker or secondhand smoke exposure, systolic blood pressure, BMI, level of high-density lipoprotein cholesterol, level of low-density lipoprotein, diabetes
Diseases: CHD and stroke
Outcomes: CHD incidence, prevalence, mortality, costs, uncertainty
Sensitivity analysis: Monte Carlo simulations
Validation: no model validation
Number of peer-reviewed articles in this search: 1
Related papers: 118
Model name/first author: Lung Cancer Policy Model
Model type (self-reported): state-transition microsimulation model
Risk factors included (smoking status provided with details): smoking history (length of time a person smoked and cigarettes smoked per day)
Diseases: three cancers from any of the following five lung cancer cell types: adenocarcinoma (including adenocarcinoma in situ), large cell, squamous cell, small cell and other
Outcomes: mortality rate and cost-effectiveness
Sensitivity analysis: performed sensitivity analysis
Validation: model validated
Number of peer-reviewed articles in this search: 1
Related papers: 69
Model name/first author: Mendez model
Model type (self-reported): Excel-based Markov model
Risk factors included (smoking status provided with details): smoking status (never, former, current)
Diseases: NA
Outcomes: cost, DALY, smoking prevalence
Sensitivity analysis: PSA
Validation: model validated
Number of peer-reviewed articles in this search: 1
Related papers: 78*
Model name/first author: Mejia model
Model type (self-reported): decision tree model used in Monte Carlo simulations
Risk factors included (smoking status provided with details): smoking status (current cigarette user, current e-cigarette, dual user)
Diseases: NA
Outcomes: morbidity, uncertainty
Sensitivity analysis: performed sensitivity analysis
Validation: no model validation
Number of peer-reviewed articles in this search: 1
Related papers: 83

*Paper mentioned that this simulation model is based on the model developed by Mendez, Warner and Courant.

BMI, body mass index; CHD, coronary heart disease; cMRTP, candidate modified risk tobacco products; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; CVD, cardiovascular disease; DALY, disability-adjusted life year; ICER, incremental cost-effectiveness ratio; IHD, ischaemic heart disease; NA, not available; PSA, probabilistic sensitivity analysis; QALY, quality-adjusted life year; ROI, return on investment; T2DM, type 2 diabetes mellitus.